Lymepak Shortage Update: What Patients Need to Know in 2026

If you're searching for an update on the Lymepak shortage, here's the clearest picture available in 2026: Lymepak is not in a temporary shortage — the brand has been permanently discontinued. Here's everything Lyme disease patients need to understand about this situation and what it means for accessing treatment.

Is Lymepak in Shortage?

Lymepak is not listed on the FDA Drug Shortages database as a current shortage — because the situation is more permanent than a shortage. According to Drugs.com, all formulations of the LymePak brand have been discontinued by the manufacturer, Chartwell RX, LLC. A discontinuation is different from a shortage: a shortage implies temporary unavailability, while a discontinuation means the brand is no longer being produced.

This means patients will not find Lymepak brand-name tablets returning to pharmacy shelves. However — and this is the critical point — the active ingredient in Lymepak, doxycycline hyclate 100 mg, remains widely available as a generic drug from multiple manufacturers.

What Was Lymepak and Why Did It Matter?

Lymepak (doxycycline hyclate 100 mg) was the only brand-name drug with FDA approval specifically for early Lyme disease. It was marketed in a convenient 14-tablet blister card or 42-tablet (3-card) package designed for a complete 21-day course. Approved in 2018 under NDA 209844, it was manufactured by Chartwell RX, LLC and indicated for adults and children ≥8 years old weighing ≥45 kg.

The Lymepak brand was unique in that it was specifically labeled and packaged for Lyme disease treatment. Generic doxycycline has been FDA-approved (in various forms) since 1967 and is used for many conditions beyond Lyme disease — but Lymepak's specific indication and packaging were designed to make Lyme disease treatment more straightforward for patients and providers.

Is Generic Doxycycline in Shortage?

As of 2026, generic doxycycline hyclate is not on the FDA's Drug Shortages database. Doxycycline has been a staple generic antibiotic for decades and is produced by numerous manufacturers. While localized or temporary stock issues at individual pharmacies can occur (as with any medication), a nationwide shortage of generic doxycycline would be unusual and would be widely reported.

The bottom line for patients: you should be able to find generic doxycycline hyclate 100 mg at most pharmacies. If your local pharmacy is out of stock, check a nearby chain or independent pharmacy.

How Does Lyme Disease Treatment Work Without Lymepak Brand?

Treatment for early Lyme disease continues exactly as it did before Lymepak was discontinued — with a 21-day course of doxycycline 100 mg taken twice daily. The difference is that patients will receive generic doxycycline hyclate tablets rather than the Lymepak-branded blister cards.

Clinical studies have shown that doxycycline-treated early Lyme disease patients achieve a 75–95% response rate at 6 months, compared to 56–66% in untreated patients. The efficacy of treatment is in the drug itself (doxycycline hyclate), not the brand name packaging.

38,404+ patients found their medications in stock

38K+

Find Lymepak In Stock Today →

What About Cost? Does the Discontinuation Affect Price?

Actually, the discontinuation of the Lymepak brand is likely to be beneficial for most patients' wallets. The brand-name Lymepak was priced at approximately $2,549 retail for a 42-tablet supply at some pharmacies. In contrast, generic doxycycline hyclate 100 mg is available for as little as $8–$18 with a GoodRx coupon for a comparable supply. Insurance plans cover generic doxycycline at Tier 1, typically with a $0–$15 copay.

Steps for Patients Right Now

If you were prescribed Lymepak: Ask your pharmacist for generic doxycycline hyclate 100 mg tablets. It's the same drug.

If your pharmacy is out of generic doxycycline: Call nearby pharmacies or use a service like medfinder to locate it quickly.

If you cannot tolerate doxycycline: Discuss alternatives (amoxicillin, cefuroxime) with your doctor.

Don't delay treatment: Early Lyme disease treated promptly has excellent outcomes. Delay increases the risk of dissemination to joints, heart, or nervous system.

Skip the calls, skip the stress.

Find Lymepak In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

The Bottom Line for Lyme Disease Patients in 2026

The Lymepak brand discontinuation does not mean Lyme disease patients are without treatment options. Generic doxycycline hyclate is widely available, much more affordable, and equally effective. If you're struggling to locate it, medfinder can help you find a pharmacy with stock near you. And if doxycycline isn't right for your situation, explore the alternatives to Lymepak with your doctor.